These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

949 related articles for article (PubMed ID: 33974165)

  • 21. Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection.
    Zhang Q; Bignotti A; Yada N; Ye Z; Liu S; Han Z; Zheng XL
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study.
    De Cristofaro R; Liuzzo G; Sacco M; Lancellotti S; Pedicino D; Andreotti F
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):285-289. PubMed ID: 33443926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study.
    Sánchez-Santillán RN; Sierra-Vargas MP; González-Islas D; Aztatzi-Aguilar OG; Pérez-Padilla R; Orea-Tejeda A; Debray-García Y; Ortega-Romero M; Keirns-Davis C; Loaeza-Roman A; Rios-Pereda A
    BMC Pulm Med; 2024 Jul; 24(1):325. PubMed ID: 38965511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
    Xu X; Feng Y; Jia Y; Zhang X; Li L; Bai X; Jiao L
    Thromb Res; 2022 Oct; 218():83-98. PubMed ID: 36027630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.
    Bongers TN; Emonts M; de Maat MP; de Groot R; Lisman T; Hazelzet JA; Leebeek FW
    Thromb Haemost; 2010 Jun; 103(6):1181-7. PubMed ID: 20390223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linear relationship between ADAMTS13 activity and platelet dynamics even before severe thrombocytopenia.
    Song J; Lee KA; Park TS; Park R; Choi JR
    Ann Clin Lab Sci; 2008; 38(4):368-75. PubMed ID: 18988930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
    Reiter RA; Knöbl P; Varadi K; Turecek PL
    Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet Count, ADAMTS13 Activity, von Willebrand Factor Level and Survival in Patients with Colorectal Cancer: 5-Year Follow-up Study.
    Garam N; Maláti É; Sinkovits G; Gombos T; Szederjesi A; Barabás L; Gráf L; Kocsis J; Prohászka Z
    Thromb Haemost; 2018 Jan; 118(1):123-131. PubMed ID: 29304532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lasting prothrombotic state implied by changes of plasma von Willebrand factor parameters after radical prostatectomy for prostate malignancy.
    Harsfalvi J; Molnar Z; Csanyi MC; Domjan I; Flasko T; Kaposi A; Benyo M
    Urol Oncol; 2020 Apr; 38(4):191-197. PubMed ID: 31711834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.
    Ward SE; Curley GF; Lavin M; Fogarty H; Karampini E; McEvoy NL; Clarke J; Boylan M; Alalqam R; Worrall AP; Kelly C; de Barra E; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Townsend L; Mallon PW; O'Sullivan JM; O'Donnell JS;
    Br J Haematol; 2021 Feb; 192(4):714-719. PubMed ID: 33326604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAMTS-13-VWF axis in sickle cell disease patients.
    Ladeira VS; Barbosa AR; Oliveira MM; Ferreira LGR; de Oliveira Júnior WV; de Oliveira Renó C; Reis EA; Chaves DG; Dusse LMS; Dos Santos HL; de Barros Pinheiro M; Rios DRA
    Ann Hematol; 2021 Feb; 100(2):375-382. PubMed ID: 33404693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.
    Murphy SJX; Lim ST; Hickey F; Kinsella JA; Smith DR; Tierney S; Egan B; Feeley TM; Murphy SM; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; O'Donnell JS; O'Sullivan JM; Hamilton G; McCabe DJH
    Thromb Haemost; 2021 Jan; 121(1):86-97. PubMed ID: 32932544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy.
    Seth R; McKinnon TAJ; Zhang XF
    Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H87-H93. PubMed ID: 34890277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity.
    Dyer MR; Plautz WE; Ragni MV; Alexander W; Haldeman S; Sperry JL; Guyette FX; Zuckerbraun BS; Rollins-Raval MA; Raval JS; Neal MD;
    Transfusion; 2020 Jun; 60(6):1308-1318. PubMed ID: 32441353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAMTS13 regulation of VWF multimer distribution in severe COVID-19.
    Ward SE; Fogarty H; Karampini E; Lavin M; Schneppenheim S; Dittmer R; Morrin H; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Mallon PW; Curley GF; Baker RI; Budde U; O'Sullivan JM; O'Donnell JS;
    J Thromb Haemost; 2021 Aug; 19(8):1914-1921. PubMed ID: 34053187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm.
    Fujimura Y; Holland LZ
    Int J Hematol; 2022 Apr; 115(4):457-469. PubMed ID: 35316498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
    Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.